Sloan Sheldon
Chief Medical Officer
CIK: 2038798
All Transactions
| Date | Company | Type | Shares | Price | Value | Actions |
|---|---|---|---|---|---|---|
| Jul 1, 2026 | Spyre Therapeutics, Inc. (SYRE) | S | 6,500 | $87.52 | $568,880.00 | View Details Filing |
| Jul 1, 2026 | Spyre Therapeutics, Inc. (SYRE) | S | 1,834 | $88.34 | $162,015.56 | View Details Filing |
| Jun 3, 2026 | Spyre Therapeutics, Inc. (SYRE) | S | 8,333 | $75.00 | $624,975.00 | View Details Filing |
| May 1, 2026 | Spyre Therapeutics, Inc. (SYRE) | S | 400 | $75.37 | $30,148.00 | View Details Filing |
| May 1, 2026 | Spyre Therapeutics, Inc. (SYRE) | S | 12,777 | $72.94 | $931,954.38 | View Details Filing |
| May 1, 2026 | Spyre Therapeutics, Inc. (SYRE) | S | 10,358 | $73.74 | $763,798.92 | View Details Filing |
| May 1, 2026 | Spyre Therapeutics, Inc. (SYRE) | S | 21,306 | $69.53 | $1,481,406.18 | View Details Filing |
| May 1, 2026 | Spyre Therapeutics, Inc. (SYRE) | S | 8,777 | $71.56 | $628,082.12 | View Details Filing |
| May 1, 2026 | Spyre Therapeutics, Inc. (SYRE) | S | 19,656 | $70.61 | $1,387,910.16 | View Details Filing |
| May 1, 2026 | Spyre Therapeutics, Inc. (SYRE) | S | 5,059 | $74.60 | $377,401.40 | View Details Filing |